MONDAY, Oct. 6, 2025 (HealthDay News) — Costco shoppers will be able fill prescriptions for Ozempic and Wegovy — two of the most popular weight loss and diabetes drugs — at a discount. Novo Nordisk, the maker of both medications, announced Friday that the warehouse retailer will sell a four-weekContinue Reading
TUESDAY, Sept. 30, 2025 (HealthDay News) — People with severe obesity are likely to face discrimination when seeking health care, with many clinics outright refusing to see them, a new study says. About 2 in 5 (41%) of clinics refused to schedule an appointment for a hypothetical patient weighing 465Continue Reading
-690x550.jpg)
SUNDAY, Sept. 28, 2025 (HealthDay News) — It sounds counterintuitive: Eat more fat and lose more weight. But it’s the underpinning of a keto diet — a controversial eating regimen designed to retrain the body to rely on something other than sugar for energy. The regimen is rich in meat,Continue Reading
WEDNESDAY, Sept. 24, 2025 (HealthDay News) — A pill form of the blockbuster weight-loss drug Ozempic can help overweight or obese folks shed excess pounds, a new clinical trial has concluded. People who took a daily semaglutide pill lost nearly 14% of their body weight over 64 weeks, compared withContinue Reading
FRIDAY, Sept. 19, 2025 (HealthDay News) — Cutting-edge drugs like Ozempic and Zepbound are all the rage for dropping excess pounds, but weight-loss surgery might have a better impact on people’s health, a new study says. People who had weight-loss surgery lost more weight, lived longer and faced fewer seriousContinue Reading
WEDNESDAY, Sept. 17, 2025 (HealthDay News) — A popular weight-loss drug may do more than help patients shed pounds. It could also help quiet the nonstop food cravings many people struggle with. New results from a U.S. survey of 550 Wegovy users found that patients reported a major drop inContinue Reading
The purpose of the list is to keep unverified and unapproved GLP-1 drug ingredients from entering the countryContinue Reading
WEDNESDAY, Sept. 3, 2025 (HealthDay News) — The weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, according to new research from its maker, Novo Nordisk. In a study of more than 21,000 patients with obesity and heart disease but no diabetes,Continue Reading
WEDNESDAY, Aug. 27, 2025 (HealthDay News) — Eli Lilly says its new once-daily pill, orforglipron, helped people lose significant weight and lower blood sugar in a late-stage clinical trial. The company plans to seek global regulatory approval later this year. The study included people with overweight, obesity and type 2Continue Reading
System integrates glucose biosensor with an AI-driven platform to show how food, activity, stress, sleep affect the body in real timeContinue Reading